Filter
4916
Filtered Results: 4916
Text search:
Essential
Medicine
Featured
Recommendations
473
New Publications
1238
Language
Document type
No document type
2571
Studies & Reports
922
Guidelines
736
Manuals
287
Strategic & Response Plan
160
Training Material
106
Fact sheets
61
Situation Updates
40
Resource Platforms
13
Brochures
8
Infographics
7
Online Courses
2
Videos
2
App
1
Countries / Regions
India
259
Global
198
Kenya
145
South Africa
118
Ethiopia
114
Nepal
102
Uganda
93
Sierra Leone
88
Nigeria
76
Liberia
74
Western and Central Europe
74
Africa
72
Malawi
69
Latin America and the Carribbean
67
Tanzania
64
Bangladesh
64
Zambia
58
Myanmar / Burma
58
Ghana
56
Syria
56
Ukraine
51
Rwanda
45
Mozambique
43
Brazil
43
Namibia
41
Philippines
40
Congo, Democratic Republic of
37
South–East Asia Region
31
Senegal
28
Lesotho
26
Eastern Europe
26
Guinea
23
Asia
23
East and Southern Africa
22
West and Central Africa
21
Burkina Faso
20
Zimbabwe
20
Russia
20
Cambodia
19
Cameroon
17
Haiti
17
Indonesia
17
Venezuela
17
Botswana
16
Yemen
16
South Sudan
15
Germany
15
Benin
14
Eswatini/ Swaziland
14
Angola
14
Afghanistan
13
Middle East and North Africa
12
Eastern Europe and Central Asia
12
USA
10
Thailand
10
Colombia
10
Somalia
9
Lebanon
9
Sudan
9
Western Pacific Region
9
Mali
8
Pakistan
8
Jordan
8
Peru
7
Sri Lanka
7
Paraguay
7
Vietnam
7
Guinea-Bissau
6
Côte d’Ivoire / Ivory Coast
6
Iraq
6
China
6
Chile
6
Albania
6
Laos
6
Tajikistan
6
Turkey
5
North Macedonia
5
Bolivia
5
Madagascar
5
Mexico
5
Southern Africa
5
Moldova
5
Kyrgyzstan
5
Georgia
5
United Kingdom
5
Portugal
5
Papua New Guinea
4
Argentina
4
Poland
4
Palestine
4
Kazakhstan
4
Jamaica
4
Niger
3
Chad
3
Central African Republic
3
Hungary
3
Ecuador
3
Greece
3
Libya
3
Fiji
3
Bhutan
3
Canada
3
Timor Leste/ East Timor
3
Romania
3
North America
3
France
3
Morocco
2
Saudi Arabia
2
Egypt
2
Serbia
2
Burundi
2
Other region
2
Armenia
2
Mongolia
2
Congo-Brazzaville
2
Iran
2
Japan
2
Mauritius
2
Bosnia and Herzegovina
2
Togo
1
Gambia
1
Singapore
1
Guatemala
1
Nicaragua
1
Solomon Islands
1
Qatar
1
Bulgaria
1
Estonia
1
Lithuania
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
French Guyana
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1806
Clinical Guidelines
484
Public Health
314
Women & Child Health
258
Key Resources
155
Capacity Building
100
Pharmacy & Technologies
70
Annual Report MEDBOX
1
Toolboxes
COVID-19
415
Mental Health
409
HIV
335
TB
263
AMR
236
Pharmacy
186
Caregiver
177
Planetary Health
151
Disability
135
NCDs
130
Rapid Response
123
NTDs
123
Conflict
116
Ebola
111
Global Health Education
78
Refugee
59
Natural Hazards
41
Health Financing Toolbox
38
Social Ethics
29
Specific Hazards
28
Zika
20
Cholera
13
Polio
13
Health Financing
2
Ethiopia National Essential Medicine List
recommended
6 edition
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier met...
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulati...
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (Table 1) are based on guidelines published in 2013 i...
Background
Access to medicines is important for long‐term care of cardiovascular diseases and hypertension. This study provides a cross‐country assessment of availability, prices, and affordability of cardiovascular disease and hypertension ...s to identify areas for improvement in access to medication treatment.
Methods and Results
We used the World Health Organization online repository of national essential medicines lists (EMLs) for 53 countries to transcribe the information on the inclusion of 12 cardiovascular disease/hypertension medications within each country's essential medicines list. Data on availability, price, and affordability were obtained from 84 surveys in 59 countries that used the World Health Organization's Health Action International survey methodology. We summarized and compared the indicators across lowest‐price generic and originator brand medicines in the public and private sectors and by country income groups. The average availability of the select medications was 54% in low‐ and lower‐middle‐income countries and 60% in high‐ and upper‐middle‐income countries, and was higher for generic (61%) than brand medicines (41%). The average patient median price ratio was 80.3 for brand and 16.7 for generic medicines and was higher for patients in low‐ and lower‐middle‐income countries compared with high‐ and upper‐middle‐income countries across all medicine categories. The costs of 1 month's antihypertensive medications were, on average, 6.0 days’ wage for brand medicine and 1.8 days’ wage for generics. Affordability was lower in low‐ and lower‐middle‐income countries than high‐ and upper‐middle‐income countries for both brand and generic medications.
Conclusions
The availability and accessibility of pharmaceuticals is an ongoing challenge for health systems. Low availability and high costs are major barriers to the use of and adherence to essential cardiovascular disease and antihypertensive medications worldwide, particularly in low‐ and lower‐middle‐income countries.
High variability in the definition and interpretation of organized cancer screening needs to be addressed systematically. Moreover, the relevance of the current practice of categorizing screening programmes dichotomously into organized or non-organized needs to be revisited in the context of conside...
Demographic and epidemiological transitions are changing the age structure of the population and the most common diseases. Non-communicable respiratory diseases are an increasing problem at both ends of the age range in low-income and middle-income countries. In children, who represent a large propo...
The 6th edition of the essential medicine list has been developed based on the 5th edition list of essential ...s, the National Standard Treatment Guidelines and Protocols 2013, list of laboratory commodities and List of Consumables used in public health facilities.
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WH...
Chapter 16: Managing medicine selection - Key topics: the concept of essential medicines; selection of ... medicines and development of essential medicines lists, formularies, and treatment guidelines. - The rationale for selecting a limited number of essential medicines is that it may lead to better supply, more rational use, and lower costs.
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee consi...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicine...
The clinical guidelines and protocols for the practice of emergency medicine presented in this document are designed to be a useful resource not only for those wishing to become emergency medicine s...
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We ...
The aim of these Guidelines is to provide a framework for the conservation and sustainable use of plants in medicine. To do this, the Guidelines describe the various tasks that should be carried out to ensure that where ...al plants are taken from the wild, they are taken on a basis that is sustainable.
The Guidelines conform to the principles of Caring for the Earth, prepared in partnership by IUCN, UNEP and WWF. Caring for the Earth extends the message and scope of the World Conservation Strategy to an ethic of sustainable living, and explains how to integrate conservation with development. Its message is particularly relevant to the issue of medicinal plants, which in many parts of the world are being seriously depleted due to over-exploitation and loss of habitats, resulting in a lack of essential medicines and so reducing options for the future.
The Guidelines conform to the principles of Caring for the Earth, prepared in partnership by IUCN, UNEP and WWF. Caring for the Earth extends the message and scope of the World Conservation Strategy to an ethic of sustainable living, and explains how to integrate conservation with development. Its message is particularly relevant to the issue of medicinal plants, which in many parts of the world are being seriously depleted due to over-exploitation and loss of habitats, resulting in a lack of essential medicines and so reducing options for the future.
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing ...
This manual has been designed to be used in conjunction with two earlier WHO publications, "Basic tests for pharmaceutical substances" (1986) and "Basic tests for pharmaceutical dosage forms" (1991). Most of the pharmaceutical substances and dosage forms covered are included in the WHO Model List of...
The document contains a set of indicators that can be used for monitoring traditional and complementary medicine (T&CM) systems in a country.
The core indicator set consists of 16 indicators that were considered ... and collectively able to provide information on T&CM inputs, processes and outputs. A longer list of reference indicators is also available for countries that wish to monitor more indicators or that want to consider alternative metrics that would better suit each country’s T&CM situation, priorities and monitoring capacities.
Each core and reference indicator is accompanied by a set of metadata. This provides information on the indicator rationale, definitions, data elements (numerator, denominator and data disaggregation), frequency of measurement, and data sources. It is a guide towards more standardized data measurement as well as data interpretation.
